HOLX
Price:
$81.57
Market Cap:
$18.95B
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in as...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
1990-03-01
Stock Exchange
NASDAQ
Ticker
HOLX
According to Hologic, Inc.’s latest financial reports and current stock price. The company's current ROE is 14.41%. This represents a change of 296.60% compared to the average of 3.63% of the last 4 quarters.
The mean historical ROE of Hologic, Inc. over the last ten years is 16.48%. The current 14.41% ROE has changed -12.51% with respect to the historical average. Over the past ten years (40 quarters), HOLX's ROE was at its highest in in the December 2020 quarter at 20.03%. The ROE was at its lowest in in the March 2018 quarter at -27.86%.
Average
16.48%
Median
12.26%
Minimum
-4.58%
Maximum
44.36%
Discovering the peaks and valleys of Hologic, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 654.77%
Maximum Annual ROE = 44.36%
Minimum Annual Increase = -2437.17%
Minimum Annual ROE = -4.58%
Year | ROE | Change |
---|---|---|
2023 | 9.09% | -65.96% |
2022 | 26.70% | -39.81% |
2021 | 44.36% | 7.61% |
2020 | 41.22% | -2437.17% |
2019 | -1.76% | -61.51% |
2018 | -4.58% | -116.89% |
2017 | 27.13% | 75.73% |
2016 | 15.44% | 143.92% |
2015 | 6.33% | 654.77% |
2014 | 0.84% | -101.39% |
The current ROE of Hologic, Inc. (HOLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
26.72%
5-year avg
23.92%
10-year avg
16.48%
Hologic, Inc.’s ROE is less than Haemonetics Corporation (12.41%), greater than ICU Medical, Inc. (-3.40%), greater than Envista Holdings Corporation (-33.98%), less than The Cooper Companies, Inc. (4.64%), less than West Pharmaceutical Services, Inc. (19.08%), less than Teleflex Incorporated (5.92%), less than Alcon Inc. (5.34%), less than ResMed Inc. (22.41%), less than Becton, Dickinson and Company (5.51%), less than Merit Medical Systems, Inc. (9.48%), greater than AngioDynamics, Inc. (-58.84%), less than AptarGroup, Inc. (13.84%),
Company | ROE | Market cap |
---|---|---|
12.41% | $3.75B | |
-3.40% | $3.96B | |
-33.98% | $3.00B | |
4.64% | $21.23B | |
19.08% | $21.56B | |
5.92% | $11.52B | |
5.34% | $46.70B | |
22.41% | $35.98B | |
5.51% | $67.25B | |
9.48% | $5.62B | |
-58.84% | $288.78M | |
13.84% | $10.12B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hologic, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hologic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Hologic, Inc.'s ROE?
How is the ROE calculated for Hologic, Inc. (HOLX)?
What is the highest ROE for Hologic, Inc. (HOLX)?
What is the 3-year average ROE for Hologic, Inc. (HOLX)?
What is the 5-year average ROE for Hologic, Inc. (HOLX)?
How does the current ROE for Hologic, Inc. (HOLX) compare to its historical average?